Mohammed Shameem, Ph.D.

Senior Vice President
Regeneron Pharmaceuticals, Inc.

Poster(s):

• (T0930-08-48) Development of a Novel Stabilizer for Biotherapeutic Antibody Formulations with Residual Lipase Activity
  Tuesday, November 11, 2025

  9:30 AM - 10:30 AM CT

• (W1030-07-45) A Novel Basic Charge Variant Observed in Late-Stage mAb-1 Identified as High Molecular Weight Species
  Wednesday, November 12, 2025

  10:30 AM - 11:30 AM CT

• (T1330-02-09) Evaluating Static and Dynamic Interactions between Preservative and Tubing during Filling of Parenteral Liquid Formulations
  Tuesday, November 11, 2025

  1:30 PM - 2:30 PM CT

• (T1330-07-46) Evaluation of Next-Generation Lipids with Varying Chemistries for Enhancing the Endosomal Escape and Extrahepatic Delivery Potential of mRNA-LNP Therapeutics
  Tuesday, November 11, 2025

  1:30 PM - 2:30 PM CT

• (M1530-06-37) Effective Methods for Ensuring Dose Accuracy in Low Volume Drug Transfers Using Closed System Transfer Devices
  Monday, November 10, 2025

  3:30 PM - 4:30 PM CT